Efficacy and Safety of Neoadjuvant Chemotherapy Followed by <scp>CDK4</scp> /6 Inhibitors Plus Endocrine Therapy in Patients With <scp>HR</scp> ‐Positive, <scp>HER2</scp> ‐Negative Breast Cancer: A Retrospective Single‐Centre Cohort Analysis

Xiaopei Dong, Fan Li, Yang Yuan, Hua Song, Yingzhe Wang, Yi Hao, Yinping Dong, Tao Wang, Li Bian, Shaohua Zhang, Jianbin Li

Open source

DOI: 10.1002/cam4.72258
Published: 2026-09
Container: Cancer Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cam4.72258,
  title = {Efficacy and Safety of Neoadjuvant Chemotherapy Followed by
                    <scp>CDK4</scp>
                    /6 Inhibitors Plus Endocrine Therapy in Patients With
                    <scp>HR</scp>
                    ‐Positive,
                    <scp>HER2</scp>
                    ‐Negative Breast Cancer: A Retrospective Single‐Centre Cohort Analysis},
  author = {Xiaopei Dong and Fan Li and Yang Yuan and Hua Song and Yingzhe Wang and Yi Hao and Yinping Dong and Tao Wang and Li Bian and Shaohua Zhang and Jianbin Li},
  year = {2026},
  journal = {Cancer Medicine},
  doi = {10.1002/cam4.72258},
  url = {https://doi.org/10.1002/cam4.72258}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Neoadjuvant Chemotherapy Followed by
                    <scp>CDK4</scp>
                    /6 Inhibitors Plus Endocrine Therapy in Patients With
                    <scp>HR</scp>
                    ‐Positive,
                    <scp>HER2</scp>
                    ‐Negative Breast Cancer: A Retrospective Single‐Centre Cohort Analysis
AU  - Xiaopei Dong
AU  - Fan Li
AU  - Yang Yuan
AU  - Hua Song
AU  - Yingzhe Wang
AU  - Yi Hao
AU  - Yinping Dong
AU  - Tao Wang
AU  - Li Bian
AU  - Shaohua Zhang
AU  - Jianbin Li
PY  - 2026
JO  - Cancer Medicine
DO  - 10.1002/cam4.72258
UR  - https://doi.org/10.1002/cam4.72258
ER  -

APA

Dong, X., Li, F., Yuan, Y., Song, H., Wang, Y., Hao, Y., Dong, Y., Wang, T., Bian, L., Zhang, S., & Li, J. (2026). Efficacy and Safety of Neoadjuvant Chemotherapy Followed by <scp>CDK4</scp> /6 Inhibitors Plus Endocrine Therapy in Patients With <scp>HR</scp> ‐Positive, <scp>HER2</scp> ‐Negative Breast Cancer: A Retrospective Single‐Centre Cohort Analysis. Cancer Medicine. https://doi.org/10.1002/cam4.72258

Source records

crossref · retrieved 2026-09-25T18:01:33.146Z